Developer docs
API playgroundTry for free, no card

Search company profiles

Hanseler

Full company profile

uuid000rysz

Namestring
Hanseler
Legal namestring
Hänseler AG
Websiteurl
haenseler.ch
Company typeenum
Private
Founded yearint
1964
Descriptiontext

Hänseler AG is a privately held Swiss pharmaceutical production and trading company headquartered in Herisau, Switzerland, founded in 1964 and majority-owned by the Steinegg Stiftung. The company operates three integrated business lines: (1) pharmaceutical raw materials trading with a portfolio of more than 3,000 SKUs including essential oils, chemicals, extracts, tinctures, herbs, vitamins, and acids; (2) manufacturing and distribution of OTC preparations under proprietary brands (Gly-Coramin, Kelosoft, Mavena, Hänseler D-Mannose, Hänseler Menopause) and licensed brands (Original Bach/RESCUE, OLBAS, Bronchostop, Probactiol); and (3) CDMO (Contract Development and Manufacturing Organization) services spanning product development, sourcing, manufacturing, and packaging of liquid, semi-solid, and solid dosage forms under GMP standards with 12,000-liter liquid tanks and 500 tonnes of annual production capacity.

The company is GMP, GDP, and Swissmedic certified, bio.inspecta certified for organic products, holds a narcotics handling license, and successfully passed an FDA audit in 2022. Distribution reaches nearly all of Switzerland's approximately 1,800 pharmacies and 400 drugstores via a regional outside sales force, plus major retail chains (Migros, Coop) for consumer brands. B2B customers include industrial CDMO partners in pharmaceutical, cosmetics, and food industries served through dedicated key account managers, and international/export customers sourcing raw materials. Exclusive Swiss distribution partnerships exist with Frey+Lau (essential oils), Klenk (natural ingredients), and IOI Oleo (oleochemicals).

Hänseler generates revenue through three primary streams: OTC product sales via pharmacy and drugstore channels, raw material trading with both branded and in-house manufactured products, and CDMO contract manufacturing services. B2B online shop access requires verified business customer status with minimum order thresholds. The company's growth posture is signaled by the April 2026 inauguration of a new GMP production building, expansion to two-shift operations in February 2024, and incremental international market entries including THMP approvals in Spain, Norway, and Sweden and operations in Germany and China.

Short descriptiontext

Hänseler AG is a Swiss GMP-certified pharmaceutical company operating three integrated lines: pharmaceutical raw materials trading (3,000+ SKUs), OTC brand manufacturing and distribution, and CDMO services in liquid, semi-solid, and solid dosage forms serving Swiss pharmacies, drugstores, and industrial partners.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersHerisau, Switzerland
HQ citystring
Herisau
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical contract manufacturing, OTC pharmaceutical products, pharmaceutical raw materials, GMP-certified manufacturing, CDMO services
Industry5 codes
PRIMARYHLAGABAG
Drug Substance–Drug Product Integrated CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAA
Small-Molecule API & Intermediates CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAB
Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAJ
Packaging, Labeling & Serialization (Clinical/Commercial) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAIABAI
Contract Development & Manufacturing for Generics (CDMO/CMO)
NAICS code3 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Pharmaceutical and Medicine Manufacturing32541
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
Product category
Pharmaceutical Contract Manufacturing
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1OTC Pharmaceutical Product Sales
TypeOne Time License
Description

Sale of proprietary OTC preparations including Gly-Coramin, Bach Flower Remedies/RESCUE, OLBAS, Kelosoft, Mavena, Bronchostop, Probactiol, and others through Swiss pharmacies and drugstores. Revenue from finished dosage form products sold under company-owned and licensed brands.

haenseler.ch
2Pharmaceutical Raw Material Trading
TypeOne Time License
Description

Trading and further processing of over 3,000 pharmaceutical raw materials including essential oils, chemicals, extracts, tinctures, herbs, vitamins, salts, and acids. Materials sold as registered brand products or manufactured in-house. Serves Swiss pharmacies, drugstores, and industrial/export customers.

haenseler.ch
3CDMO Contract Manufacturing
TypeProfessional Services
Description

Contract development and manufacturing services for partner firms in pharmaceutical, cosmetics, and food industries. Services span from product development and raw material sourcing through manufacturing, packaging, and market access support. Includes exclusive trading access and toll manufacturing capabilities.

haenseler.ch
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1B2B Online Shop for verified business customers
ModelOtherBilling cadencePay-as-you-go
Notes

Free shipping from CHF 100 for pharmacies and drugstores; CHF 500 for industrial customers. Over 1,000 products available immediately from stock.

haenseler.ch
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 13 records shown
1RESCUE
Description

Bach flower emergency remedy product line for emotional balance and well-being

haenseler.ch
+12 more records
Core offering1 text field

Hänseler AG is a Swiss GMP-certified pharmaceutical CDMO that develops, sources, manufactures, and packages liquid, semi-solid, and solid dosage forms for industrial partners. The company also produces and distributes its own OTC preparations under proprietary and licensed brands and trades more than 3,000 pharmaceutical raw materials to pharmacies, drugstores, and industrial/export customers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Nearly all of Switzerland's 1,800 pharmacies and 400 drugstores are Hänseler customers
+3 more records
Product overview1 text field

Hänseler AG is a Swiss pharmaceutical company offering OTC preparations and CDMO services. The product portfolio encompasses medicines, medical devices, food supplements, and cosmetics, with key brands including Gly-Coramin® (energy), RESCUE® (Bach® flower essences for emotional wellness), OLBAS® and Bronchostop® (respiratory), Hänseler D-Mannose and Nieren- und Blasendragées S (urinary tract), Mavena B12 (dermatological), Probactiol® (probiotics), and Kelosoft® (acquired scar treatment brand). The company operates as both a product manufacturer/distributor and a CDMO (Contract Development and Manufacturing Organization) providing development, sourcing, manufacturing, packaging, and market access services for liquid, semi-solid, and solid dosage forms. Raw materials include over 3,000 pharmaceutical-grade substances. The CDMO services are organized into Liquid Solutions, Semi-Solid Solutions, and Solid Solutions, supported by documentation packages for regulatory compliance.

Product and service12 records
1CDMO Services
CategoryCDMO contract manufacturing services
Description

Full-service pharmaceutical contract development and manufacturing including product development, raw material sourcing, GMP manufacturing, packaging, regulatory documentation, and Swiss market access support for pharmaceutical, cosmetics, and food industry partners.

2Pharmaceutical Raw Materials
CategoryPharmaceutical raw materials trading
Description

Catalog of more than 3,000 pharmaceutical-grade raw materials including essential oils, extracts, tinctures, herbs, vitamins, salts, acids, chemicals, and excipients supplied to pharmacies, drugstores, and industrial customers with full regulatory documentation.

3RESCUE Product Line
CategoryOTC pharmaceutical brand
Description

Bach flower essence product line including Original Bach Blüten 1-38 and RESCUE emergency drops for emotional wellness and stress relief, distributed in Swiss specialist retail.

4Gly-Coramin Brand
CategoryOTC pharmaceutical brand
Description

Energy and circulation stimulant product including Gly-Coramin tablets for fatigue and altitude discomfort and Gly-Cora Boost caffeine toffee for on-demand energy, sold through Swiss pharmacies and drugstores.

5Olbas
CategoryOTC pharmaceutical brand
Description

Essential-oil-based herbal medicine for cold symptoms including rhinitis, sore throat, and cough, sold through Swiss pharmacies and drugstores.

6Bronchostop Product Line
CategoryOTC pharmaceutical brand
Description

Herbal cough remedy range including Bronchostop DUO lozenges, DUO syrup, and Bronchostop Junior products for adults and children.

7Kelosoft
CategoryOTC pharmaceutical brand
Description

Topical scar therapy cream containing green oil from henbane for scar treatment and skin care.

8Mavena Product Line
CategoryOTC pharmaceutical brand
Description

Dermatological product range with vitamin B12 for dry, itchy, and flaky skin including gel, cream, lotion, shampoo, and intensive care formulations.

9Probactiol Product Line
CategoryOTC pharmaceutical brand
Description

Probiotic supplement range including Probactiol 10 Plus and Probactiol 25 with live bacterial cultures for digestive health.

10Hänseler D-Mannose Product Family
CategoryOTC pharmaceutical brand
Description

D-Mannose based product family including Direct, Nature, Plus, and Gel variants for urinary tract support and intimate area care.

11Nieren- und Blasendragées S
CategoryOTC pharmaceutical brand
Description

Herbal medicine for irritation of the urinary tract sold in Swiss pharmacies and exported to Norway.

12Tea Drugs / Medicinal Plants
CategoryPharmaceutical raw materials category
Description

GMP-certified assortment of medicinal plants and tea drugs for pharmaceutical tea manufacturing, compliant with Swissmedic and European Pharmacopoeia standards.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Frey+Lau is represented by Hänseler AG exclusively in Switzerland for essential oils. Hänseler distributes Frey+Lau's full range including pharmaceutical quality essential oils, excipient-grade oils, bio/organic certified oils, and aroma chemicals to the Swiss market. Product lists available for download including Wirkstoffe (active substances), Hilfsstoffe (excipients), and Bio quality.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Klenk is represented by Hänseler AG exclusively in Switzerland as a natural ingredients supplier. Klenk specializes in natural raw materials and botanical ingredients for pharmaceutical, cosmetic, and food applications.

3IOI Oleo GmbH
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

IOI Oleo GmbH is represented by Hänseler AG exclusively in Switzerland for oleochemical products. IOI Oleo supplies specialty oleochemicals used in pharmaceutical, cosmetic, and food industry applications.

haenseler.ch
Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Swiss-listed CDMO with API and finished dosage form manufacturing for small molecules. Directly comparable to Hänseler as a Swiss-headquartered CDMO offering integrated drug substance and drug product services, although at substantially larger scale.

TypeDirect peer
Description

Swiss specialty CDMO focused on hazardous chemistry and APIs/intermediates. Comparable to Hänseler's intermediates trading (GID) and small-molecule manufacturing focus, with similar Swiss regulatory pedigree.

TypeBroad incumbent
Description

Swiss-headquartered global CDMO leader across small molecules, biologics, and cell/gene therapy. Overlaps with Hänseler on small-molecule and integrated CDMO services but operates at vastly greater scale and breadth.

TypeBroad incumbent
Description

Large global CDMO with deep capabilities in oral solid, sterile fill-finish, and softgel dosage forms. Competes with Hänseler for small-molecule drug product CDMO mandates, but at much larger scale and geographic footprint.

TypeDirect peer
Description

Swiss manufacturer of natural pharmaceuticals, anthroposophic medicines, and natural cosmetics with in-house production and proprietary brands. Comparable to Hänseler's herbal/plant-based OTC and natural raw material business, and similarly Swiss-rooted.

TypeDirect peer
Description

Swiss OTC and dermo-cosmetic manufacturer with strong Swiss pharmacy channel presence. Comparable to Hänseler's OTC and dermatology brands (e.g., Mavena) and distribution model through Swiss specialist retail.

TypeEmerging player
Description

European CDMO with solid, semi-solid, and liquid dosage form capabilities serving pharma and consumer health. Comparable mid-market competitor to Hänseler for small-to-mid sized CDMO contracts.

8Recipharm AB
TypeEmerging player
Description

European CDMO with broad small-molecule drug product capabilities across multiple sites. Comparable as a peer in the European CDMO market that Hänseler competes in for contract manufacturing customers.

9Doetsch Grether AG
TypeRegional player
Description

Swiss distributor and brand owner in pharmacy and drugstore channels. Comparable to Hänseler's OTC distribution muscle and Swiss retail relationships, although focused on distribution rather than in-house manufacturing.

TypeRegional player
Description

Leading Swiss pharmaceutical wholesaler and logistics provider. Comparable as a Swiss pharma supply chain counterpart that influences the distribution economics Hänseler faces when serving the same pharmacy and drugstore network.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance8 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Hanseler

Pharmaceutical Contract Manufacturinghaenseler.ch

Hänseler AG is a Swiss GMP-certified pharmaceutical company operating three integrated lines: pharmaceutical raw materials trading (3,000+ SKUs), OTC brand manufacturing and distribution, and CDMO services in liquid, semi-solid, and solid dosage forms serving Swiss pharmacies, drugstores, and industrial partners.

What Hanseler does

Hänseler AG is a privately held Swiss pharmaceutical production and trading company headquartered in Herisau, Switzerland, founded in 1964 and majority-owned by the Steinegg Stiftung. The company operates three integrated business lines: (1) pharmaceutical raw materials trading with a portfolio of more than 3,000 SKUs including essential oils, chemicals, extracts, tinctures, herbs, vitamins, and acids; (2) manufacturing and distribution of OTC preparations under proprietary brands (Gly-Coramin, Kelosoft, Mavena, Hänseler D-Mannose, Hänseler Menopause) and licensed brands (Original Bach/RESCUE, OLBAS, Bronchostop, Probactiol); and (3) CDMO (Contract Development and Manufacturing Organization) services spanning product development, sourcing, manufacturing, and packaging of liquid, semi-solid, and solid dosage forms under GMP standards with 12,000-liter liquid tanks and 500 tonnes of annual production capacity.

The company is GMP, GDP, and Swissmedic certified, bio.inspecta certified for organic products, holds a narcotics handling license, and successfully passed an FDA audit in 2022. Distribution reaches nearly all of Switzerland's approximately 1,800 pharmacies and 400 drugstores via a regional outside sales force, plus major retail chains (Migros, Coop) for consumer brands. B2B customers include industrial CDMO partners in pharmaceutical, cosmetics, and food industries served through dedicated key account managers, and international/export customers sourcing raw materials. Exclusive Swiss distribution partnerships exist with Frey+Lau (essential oils), Klenk (natural ingredients), and IOI Oleo (oleochemicals).

Hänseler generates revenue through three primary streams: OTC product sales via pharmacy and drugstore channels, raw material trading with both branded and in-house manufactured products, and CDMO contract manufacturing services. B2B online shop access requires verified business customer status with minimum order thresholds. The company's growth posture is signaled by the April 2026 inauguration of a new GMP production building, expansion to two-shift operations in February 2024, and incremental international market entries including THMP approvals in Spain, Norway, and Sweden and operations in Germany and China.

Hanseler firmographics

Firmographics
Name
Hanseler
Legal name
Hänseler AG
Website
https://haenseler.ch
Company type
Private
Founded year
1964
Operating status
Operating
Headcount range
51–100 employees
Short description
Hänseler AG is a Swiss GMP-certified pharmaceutical company operating three integrated lines: pharmaceutical raw materials trading (3,000+ SKUs), OTC brand manufacturing and distribution, and CDMO services in liquid, semi-solid, and solid dosage forms serving Swiss pharmacies, drugstores, and industrial partners.
Ownership category
akta.pro rank

Hanseler industry classification

Industry
Product category
Pharmaceutical Contract Manufacturing
NAICS
Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
akta.pro industry
PRIMARYHLAGABAG
Drug Substance–Drug Product Integrated CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAA
Small-Molecule API & Intermediates CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAB
Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAJ
Packaging, Labeling & Serialization (Clinical/Commercial) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAIABAI
Contract Development & Manufacturing for Generics (CDMO/CMO)

Keywords

  • Pharmaceutical contract manufacturing
  • OTC pharmaceutical products
  • Pharmaceutical raw materials
  • GMP-certified manufacturing
  • CDMO services

Where Hanseler is headquartered

Location

Headquarters

HQ city
Herisau
HQ country
Switzerland
HQ region
Europe

Offices2 records

Markets served

Hanseler business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. OTC Pharmaceutical Product Sales: Sale of proprietary OTC preparations including Gly-Coramin, Bach Flower Remedies/RESCUE, OLBAS, Kelosoft, Mavena, Bronchostop, Probactiol, and others through Swiss pharmacies and drugstores. Revenue from finished dosage form products sold under company-owned and licensed brands.
  2. Pharmaceutical Raw Material Trading: Trading and further processing of over 3,000 pharmaceutical raw materials including essential oils, chemicals, extracts, tinctures, herbs, vitamins, salts, and acids. Materials sold as registered brand products or manufactured in-house. Serves Swiss pharmacies, drugstores, and industrial/export customers.
  3. CDMO Contract Manufacturing: Contract development and manufacturing services for partner firms in pharmaceutical, cosmetics, and food industries. Services span from product development and raw material sourcing through manufacturing, packaging, and market access support. Includes exclusive trading access and toll manufacturing capabilities.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goB2B Online Shop for verified business customers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Hanseler product offering

Product offering

Core offering

Hänseler AG is a Swiss GMP-certified pharmaceutical CDMO that develops, sources, manufactures, and packages liquid, semi-solid, and solid dosage forms for industrial partners. The company also produces and distributes its own OTC preparations under proprietary and licensed brands and trades more than 3,000 pharmaceutical raw materials to pharmacies, drugstores, and industrial/export customers.

Product overview

Hänseler AG is a Swiss pharmaceutical company offering OTC preparations and CDMO services. The product portfolio encompasses medicines, medical devices, food supplements, and cosmetics, with key brands including Gly-Coramin® (energy), RESCUE® (Bach® flower essences for emotional wellness), OLBAS® and Bronchostop® (respiratory), Hänseler D-Mannose and Nieren- und Blasendragées S (urinary tract), Mavena B12 (dermatological), Probactiol® (probiotics), and Kelosoft® (acquired scar treatment brand). The company operates as both a product manufacturer/distributor and a CDMO (Contract Development and Manufacturing Organization) providing development, sourcing, manufacturing, packaging, and market access services for liquid, semi-solid, and solid dosage forms. Raw materials include over 3,000 pharmaceutical-grade substances. The CDMO services are organized into Liquid Solutions, Semi-Solid Solutions, and Solid Solutions, supported by documentation packages for regulatory compliance.

Differentiator

Problem solved

Functional benefit

Brands

  • RESCUE: Bach flower emergency remedy product line for emotional balance and well-being
  • Gly-Coramin
  • OLBAS
  • Kelosoft
  • Alcacyl
  • Mavena
  • Bronchostop
  • Probactiol
  • Nieren- und Blasendragées S
  • Planox
  • Liquid Solutions
  • Semi-Solid Solutions
  • Solid Solutions

Products and services

  • CDMO Services Full-service pharmaceutical contract development and manufacturing including product development, raw material sourcing, GMP manufacturing, packaging, regulatory documentation, and Swiss market access support for pharmaceutical, cosmetics, and food industry partners.
  • Pharmaceutical Raw Materials Catalog of more than 3,000 pharmaceutical-grade raw materials including essential oils, extracts, tinctures, herbs, vitamins, salts, acids, chemicals, and excipients supplied to pharmacies, drugstores, and industrial customers with full regulatory documentation.
  • RESCUE Product Line Bach flower essence product line including Original Bach Blüten 1-38 and RESCUE emergency drops for emotional wellness and stress relief, distributed in Swiss specialist retail.
  • Gly-Coramin Brand Energy and circulation stimulant product including Gly-Coramin tablets for fatigue and altitude discomfort and Gly-Cora Boost caffeine toffee for on-demand energy, sold through Swiss pharmacies and drugstores.
  • Olbas Essential-oil-based herbal medicine for cold symptoms including rhinitis, sore throat, and cough, sold through Swiss pharmacies and drugstores.
  • Bronchostop Product Line Herbal cough remedy range including Bronchostop DUO lozenges, DUO syrup, and Bronchostop Junior products for adults and children.
  • Kelosoft Topical scar therapy cream containing green oil from henbane for scar treatment and skin care.
  • Mavena Product Line Dermatological product range with vitamin B12 for dry, itchy, and flaky skin including gel, cream, lotion, shampoo, and intensive care formulations.
  • Probactiol Product Line Probiotic supplement range including Probactiol 10 Plus and Probactiol 25 with live bacterial cultures for digestive health.
  • Hänseler D-Mannose Product Family D-Mannose based product family including Direct, Nature, Plus, and Gel variants for urinary tract support and intimate area care.
  • Nieren- und Blasendragées S Herbal medicine for irritation of the urinary tract sold in Swiss pharmacies and exported to Norway.
  • Tea Drugs / Medicinal Plants GMP-certified assortment of medicinal plants and tea drugs for pharmaceutical tea manufacturing, compliant with Swissmedic and European Pharmacopoeia standards.

Quantifiable outcome

  • Nearly all of Switzerland's 1,800 pharmacies and 400 drugstores are Hänseler customers
  • +3 more outcomes

Companies that use Hanseler

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Hanseler technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Hanseler partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • Frey+LaucoreChannel Partner/ Reseller/ DistributorFrey+Lau is represented by Hänseler AG exclusively in Switzerland for essential oils. Hänseler distributes Frey+Lau's full range including pharmaceutical quality essential oils, excipient-grade oils, bio/organic certified oils, and aroma chemicals to the Swiss market. Product lists available for download including Wirkstoffe (active substances), Hilfsstoffe (excipients), and Bio quality.
  • KlenkcoreChannel Partner/ Reseller/ DistributorKlenk is represented by Hänseler AG exclusively in Switzerland as a natural ingredients supplier. Klenk specializes in natural raw materials and botanical ingredients for pharmaceutical, cosmetic, and food applications.
  • IOI Oleo GmbHcoreChannel Partner/ Reseller/ DistributorIOI Oleo GmbH is represented by Hänseler AG exclusively in Switzerland for oleochemical products. IOI Oleo supplies specialty oleochemicals used in pharmaceutical, cosmetic, and food industry applications.

Scale indicators10 records

Recent moves9 records

Expansion highlights5 records

Hanseler competitors and assessment

Company assessment

Direct peers

  • Siegfried Holding AG: Swiss-listed CDMO with API and finished dosage form manufacturing for small molecules. Directly comparable to Hänseler as a Swiss-headquartered CDMO offering integrated drug substance and drug product services, although at substantially larger scale.
  • Dottikon Exclusive Synthesis AG: Swiss specialty CDMO focused on hazardous chemistry and APIs/intermediates. Comparable to Hänseler's intermediates trading (GID) and small-molecule manufacturing focus, with similar Swiss regulatory pedigree.
  • Weleda AG: Swiss manufacturer of natural pharmaceuticals, anthroposophic medicines, and natural cosmetics with in-house production and proprietary brands. Comparable to Hänseler's herbal/plant-based OTC and natural raw material business, and similarly Swiss-rooted.
  • Spirig HealthCare AG: Swiss OTC and dermo-cosmetic manufacturer with strong Swiss pharmacy channel presence. Comparable to Hänseler's OTC and dermatology brands (e.g., Mavena) and distribution model through Swiss specialist retail.

Broad incumbents

  • Lonza Group AG: Swiss-headquartered global CDMO leader across small molecules, biologics, and cell/gene therapy. Overlaps with Hänseler on small-molecule and integrated CDMO services but operates at vastly greater scale and breadth.
  • Catalent, Inc. Large global CDMO with deep capabilities in oral solid, sterile fill-finish, and softgel dosage forms. Competes with Hänseler for small-molecule drug product CDMO mandates, but at much larger scale and geographic footprint.

Emerging players

  • Aenova Group GmbH: European CDMO with solid, semi-solid, and liquid dosage form capabilities serving pharma and consumer health. Comparable mid-market competitor to Hänseler for small-to-mid sized CDMO contracts.
  • Recipharm AB: European CDMO with broad small-molecule drug product capabilities across multiple sites. Comparable as a peer in the European CDMO market that Hänseler competes in for contract manufacturing customers.

Regional players

  • Doetsch Grether AG: Swiss distributor and brand owner in pharmacy and drugstore channels. Comparable to Hänseler's OTC distribution muscle and Swiss retail relationships, although focused on distribution rather than in-house manufacturing.
  • Galexis AG: Leading Swiss pharmaceutical wholesaler and logistics provider. Comparable as a Swiss pharma supply chain counterpart that influences the distribution economics Hänseler faces when serving the same pharmacy and drugstore network.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Hanseler social profiles

Digital presence

Hanseler compliance and trust

Trust signal

Compliance8 records

Hanseler financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Hanseler leadership team

Management profile

Number of profiles

Profiles1 record

Hanseler funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Hanseler M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hanseler

What does Hanseler do?

Hänseler AG is a Swiss GMP-certified pharmaceutical CDMO that develops, sources, manufactures, and packages liquid, semi-solid, and solid dosage forms for industrial partners. The company also produces and distributes its own OTC preparations under proprietary and licensed brands and trades more than 3,000 pharmaceutical raw materials to pharmacies, drugstores, and industrial/export customers.

Is Hanseler a public or private company?

Hanseler is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Hanseler founded?

Hanseler was founded in 1964. It employs 51 to 100 people.

Where is Hanseler based?

Hanseler is headquartered in Herisau, Switzerland, in the Europe region.

How does Hanseler make money?

Three revenue lines are on record. OTC Pharmaceutical Product Sales are the primary driver. The others are pharmaceutical Raw Material Trading and CDMO Contract Manufacturing.

Who are Hanseler's main competitors?

Direct peers on record are Siegfried Holding AG, Dottikon Exclusive Synthesis AG, Weleda AG and Spirig HealthCare AG. Broad incumbents are Lonza Group AG and Catalent, Inc.. Emerging players are Aenova Group GmbH and Recipharm AB. Regional players are Doetsch Grether AG and Galexis AG.

Does Hanseler have an API?

No public API is recorded for Hanseler.

What industry is Hanseler in?

Hanseler's product category is Pharmaceutical Contract Manufacturing. Its primary akta.pro industry code is HLAGABAG, Drug Substance–Drug Product Integrated CDMO, with a secondary code of HLAGABAA, Small-Molecule API & Intermediates CDMO. Its NAICS code is 325412.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales